X-71107603-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_000206.3(IL2RG):c.*133G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000542 in 387,749 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 12 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000036 ( 0 hom., 3 hem., cov: 23)
Exomes 𝑓: 0.000062 ( 0 hom. 9 hem. )
Consequence
IL2RG
NM_000206.3 3_prime_UTR
NM_000206.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.324
Genes affected
IL2RG (HGNC:6010): (interleukin 2 receptor subunit gamma) The protein encoded by this gene is an important signaling component of many interleukin receptors, including those of interleukin -2, -4, -7 and -21, and is thus referred to as the common gamma chain. Mutations in this gene cause X-linked severe combined immunodeficiency (XSCID), as well as X-linked combined immunodeficiency (XCID), a less severe immunodeficiency disorder. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0000356 (4/112245) while in subpopulation SAS AF= 0.00111 (3/2703). AF 95% confidence interval is 0.000302. There are 0 homozygotes in gnomad4. There are 3 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Hemizygotes in GnomAd4 at 3 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL2RG | NM_000206.3 | c.*133G>A | 3_prime_UTR_variant | 8/8 | ENST00000374202.7 | NP_000197.1 | ||
IL2RG | XM_047442089.1 | c.*363G>A | 3_prime_UTR_variant | 7/7 | XP_047298045.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL2RG | ENST00000374202.7 | c.*133G>A | 3_prime_UTR_variant | 8/8 | 1 | NM_000206.3 | ENSP00000363318 | P1 | ||
IL2RG | ENST00000276110.6 | n.1836G>A | non_coding_transcript_exon_variant | 6/6 | 2 | |||||
IL2RG | ENST00000512747.3 | n.1777G>A | non_coding_transcript_exon_variant | 5/5 | 2 | |||||
IL2RG | ENST00000696903.1 | n.1546G>A | non_coding_transcript_exon_variant | 7/7 |
Frequencies
GnomAD3 genomes AF: 0.0000357 AC: 4AN: 112192Hom.: 0 Cov.: 23 AF XY: 0.0000873 AC XY: 3AN XY: 34358
GnomAD3 genomes
AF:
AC:
4
AN:
112192
Hom.:
Cov.:
23
AF XY:
AC XY:
3
AN XY:
34358
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000617 AC: 17AN: 275504Hom.: 0 Cov.: 5 AF XY: 0.000115 AC XY: 9AN XY: 78446
GnomAD4 exome
AF:
AC:
17
AN:
275504
Hom.:
Cov.:
5
AF XY:
AC XY:
9
AN XY:
78446
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000356 AC: 4AN: 112245Hom.: 0 Cov.: 23 AF XY: 0.0000872 AC XY: 3AN XY: 34421
GnomAD4 genome
AF:
AC:
4
AN:
112245
Hom.:
Cov.:
23
AF XY:
AC XY:
3
AN XY:
34421
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
X-linked severe combined immunodeficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at